Emory University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Emory University sits in the top decile of US sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count).
Emory University: 1,208 sponsored US clinical trials, 208 recruiting.
Emory University sponsors 1,208 registered US clinical trials on ClinicalTrials.gov, 208 of them currently recruiting, and 767 completed. 170 of these trials are in Phase 3-4 (later-stage) and 344 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 12 trials.
Top-decile sponsor footprint
Emory University ranks in the top decile of sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
767 of 926 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,208 total, page 21 of 25
Corneal Collagen Cross-Linking for the Treatment of Progressive Keratoconus and Corneal Ectasia
NCT00567671
Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General Surgery
NCT00596687
Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA)
NCT00590044
Examining Developmental Changes in Heart Contractions of Children With Congenital Heart Defects
NCT00860327
Heart Failure Study: The Atlanta Cardiomyopathy Consortium
NCT00599014
Evaluation of BOTOX® With Rehabilitation Therapy for the Treatment of Wrist and Hand Spasticity in Post-Stroke Patients
NCT00565201
Evaluating the Effects of Stress in Pregnancy
NCT00525226
Infectivity of Norovirus in Shellfish Treated With High Hydrostatic Pressure Processing-Human Challenge Study
NCT00674336
Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2
NCT00400374
Adult Pulmonary Valve Replacement: A Simple and Reproducible Technique
NCT00384163
IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures
NCT00510783
Evaluation of Atorvastatin on Atherosclerosis Composition
NCT00576576
TPN-Induced Hyperglycemia: Impact on Clinical Outcome in Intensive Care Unit (ICU) and Non-ICU Patients
NCT00604669
The Effect of Supplemental Docosahexaenoic Acid (DHA) on Neurocognitive Outcomes in Teen and Adult Women With Phenylketonuria(PKU)
NCT00892554
Modified Perfusion for Neonatal Aortic Arch Reconstruction
NCT00490256
Clinical Effects of Vitamin D Repletion in Patients With Parkinson's Disease
NCT00571285
Ketosis Prone Diabetes in African-Americans
NCT00426413
Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients
NCT00472082
SPY Imaging System: Its Role in Pediatric Cardiac Surgery
NCT00446927
Rifaximin for Preventing Acute Graft Versus Host Disease (AGVHD)
NCT00967096
Neurobiological Principles Applied to the Rehabilitation of Stroke Patients
NCT00715520
Speckle Tracking in Pediatric Patients
NCT00489957
Virtual Reality Helmet to Test for Problems With Memory
NCT00454454
BNP Therapy Observation Unit Outcomes STudy (BOOST)
NCT00453453
Intraosseous Infusion of Unrelated Cord Blood Grafts
NCT00967525
Acupuncture for Pain and Sleep Disturbance in Knee Osteoarthritis
NCT00694447
Retrospective Pulmonary Valve Replacement Imaging
NCT00446108
Champy Versus AO for Mandible Fractures
NCT00628849
Family-Focused, Stress-Reduction Program to Improve the Health Care of Urban Children With Asthma
NCT00384813
SMART Trial Longitudinal Follow-Up:Off-Pump Versus On-Pump Coronary Artery Bypass Surgery
NCT00209053
A Comparison of Arthrocentesis, Arthroscopy and Arthroplasty in the Treatment of Temporomandibular Joint Dysfunction
NCT00636727
Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation
NCT00548847
Exercise in Chronically Paced Children
NCT00374608
Abnormal 3-D MRI Flow Patterns in Adolescents Patients With Bicuspid Aortic Valve
NCT00412386
Protocol of the Combination of Bortezomib and Tipifarnib for Relapsed or Refractory Multiple Myeloma
NCT00972712
Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes
NCT00590226
Follow Up on Freestyle Valves in Children
NCT00385112
Neurodevelopmental Outcomes in Hypoplastic Left Heart Syndrome
NCT00399555
Topical 0.4% Ketorolac and Vitreoretinal Surgery
NCT00576329
Protective Immunity Project 02
NCT00833651
Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
NCT00401778
Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer
NCT00406276
Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment
NCT00352885
Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor
NCT00314262
Efficacy and Mechanisms of GLN Dipeptide in the SICU
NCT00248638
Protective Immunity Project 01
NCT00788021
Medical Self-Management for Improving Health Behavior Among Individuals in Community Mental Health Settings
NCT00380536
Acoustic Startle Reduction In Cocaine Dependence
NCT00430690
D-cycloserine and Virtual Reality Exposure to Treat Iraq War Veterans With PTSD
NCT00356278
Vitamin B12 Status and Response to Vitamin B12 Supplementation in Patients With Parkinson's Disease
NCT00208611
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 154 |
| Phase 2 | 190 |
| Phase 3 | 36 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Emory University pipeline
208 recruiting of 1,208 indexed (17% open); 767 completed (63%).
Phase mix: 170 late (III/IV) vs 344 early (I/II) (early-phase heavy).
Top condition: Depression (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Emory University: open-pipeline peers nationwide
Peers matched on 1,208 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Emory University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,208 trials (± recruiting share)
- Northwestern University · 1,209 trials · 15% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Baylor Research Institute · 17% recruiting · 180 trials
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · 17% recruiting · 93 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
Related
What to do with this Emory University page
1,208 registered trials is a research-attention snapshot, not an endorsement of Emory University or any single study.
- 208 of Emory University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition Emory University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Emory University pipeline card: 1,208 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.